Skip to content

Mapping the Counterfeit and Diversion Epidemic in the Pharmaceutical Industry

Stephan Von Schilcher, global strategic account manager at Systech explores mapping the counterfeit and diversion epidemic in the pharmaceutical industry for out latest EPM Online Insight.

Mapping the Counterfeit and Diversion Epidemic in the Pharmaceutical Industry
Published: | 4 min read

Shutterstock

Counterfeiting and diversion plague every industry, and no brand is immune to the health and livelihood risks posed. The international trade in counterfeit and pirated goods made up roughly 2.5 percent of world trade in 2019, while fake goods accounted for up to 5.8 percent of all imports into the European Union. These figures will undoubtedly increase in the coming years. This persistent threat affects manufacturers, retailers and consumers across global markets.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information